Foundation Club 100

Helping more Australians access clinical trials

Thanks to our work over the past 22 years, thousands of Australians have already accessed clinical trials that have improved patient quality of life, prevented them from undergoing debilitating treatments, and for some, given them more time with loved ones.

However, high-quality clinical trials require significant and sustained financial investment to deliver real-world results. 

To expand our critical work, we now need to look beyond government funding. That is why we have established the MASC Trials Foundation Club 100, our first major fundraising initiative.

Be one our first donors

By joining Foundation Club 100 you will be one of the first 100 individuals to donate to MASC Trials.

As one of our first donors, you will help to expand our clinical trials operations so that more Australians can access cutting-edge advances in and approaches to melanoma and skin cancer treatment. Your donation will support our talented investigators to develop innovative therapies to improve the lives of Australians diagnosed with melanoma and skin cancer.

If you would like to make a donation by cheque or bank transfer, please email for further details.

Foundation Club 100 members

To acknowledge the generous support of our first 100 donors, we will list your name in our annual report and on our website, unless you choose to remain anonymous. We thank the following people whose donations are directly supporting our important melanoma and skin cancer research:

Prof Mark Shackleton

Anton Middendorp

David Morgan OAM

Mary Tsouvalakis

Gabrielle Byars

Mr Richard Martin

Prof Andrew Spillane

Sharon Van Buerle

A/Prof Victoria Mar

Stephen Longley

Ian Morrison

Jane Morrison

Justin Ganly

Timothy Buckley

Stephen Kerr

Matthew Cook

Aileen Boyd-Squires

MASC Trials is a registered not-for-profit research organisation (company limited by guarantee), and has an academic affiliation with Monash University, with a dedicated centre supporting its research activities, the Melanoma and Skin Cancer Research Centre, within the School of Public Health and Preventative Medicine.